Skip to main content
RYVU Therapeutics S.A. logo

RYVU Therapeutics S.A. — Investor Relations & Filings

Ticker · RVU ISIN · PLSELVT00013 LEI · 2594003WO9Q9HHAFL031 WAR Professional, scientific and technical activities
Open in API
Filings indexed 803 across all filing types
Latest filing 2025-06-26 Declaration of Voting R…
Country PL Poland
Listing WAR RVU

About RYVU Therapeutics S.A.

https://ryvu.com/

Ryvu Therapeutics is a clinical-stage drug discovery and development company specializing in novel small molecule therapies for oncology. The company's research focuses on emerging biological targets and pathways, including kinase inhibition, synthetic lethality, and immuno-oncology, to develop precise cancer treatments. Its pipeline features several candidates in various stages of development. Key clinical-stage assets include Romaciclib (RVU120), a selective CDK8/19 kinase inhibitor for treating hematologic malignancies like acute myeloid leukemia (AML) and myelofibrosis, and Dapolsertib (MEN1703), a PIM/FLT3 inhibitor. The company also advances preclinical programs, such as an MTA-cooperative PRMT5 inhibitor for solid tumors with MTAP deletion.

Recent filings

Filing Released Lang Actions
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Ryvu Therapeutics S.A. / Resolutions adopted by the General Shareholders Meeting of Ryvu Therapeutics S.A. - Content (EN)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly states it contains the 'Report Content Resolutions adopted by the General Shareholders Meeting' held on June 26th, 2025. It details the voting results ('in favor', 'against', 'abstentions') for these resolutions. This content directly relates to the outcomes of a shareholder meeting, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements'. The code for this is DVA.
2025-06-26 English
Treść uchwał podjętych przez Zwyczajne Walne Zgromadzenie Ryvu Therapeutics S.A. / Resolutions adopted by the General Shareholders Meeting of Ryvu Therapeutics S.A. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document text is very short (714 characters) and explicitly states that the content of the resolutions adopted by the Ordinary General Meeting (Zwyczajne Walne Zgromadzenie - WZ) on June 26, 2025, along with the voting results, is attached ('przekazuje w załączeniu treść uchwał'). This structure—a brief announcement stating that the detailed results/resolutions are attached—fits the definition of a Report Publication Announcement (RPA) or potentially a Declaration of Voting Results & Voting Rights Announcement (DVA). Since the core content is the official results of a general meeting (AGM/WZ), DVA is the most specific fit, detailing the voting outcomes for the resolutions passed. However, given the 'MENU VS MEAL' rule, if this were the full result set, it would be DVA. Since it is a short announcement *attaching* the results, RPA is a strong candidate. Reviewing the definitions: AGM-R is for presentations/materials shared *during* the meeting. DVA is for the *official results*. Since this document *is* the official announcement of the results (even if attached), DVA is more precise than RPA, which is usually for announcing the publication of a general report (like an Annual Report). Given the specific nature of reporting voting results from a General Meeting, DVA is the best fit, even if it's a short cover note.
2025-06-26 Polish
Powiadomienie_Justyna_Żółtek
Director's Dealing Classification · 1% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction involving a member of the Management Board ('Członek Zarządu'), Justyna Żółtek, concerning the issuance of shares as part of an incentive program ('Wydanie Akcji w ramach Programu Motywacyjnego darowizna'). Article 19 of the MAR (Market Abuse Regulation) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs). This specific type of filing, reporting insider trades or transactions by management, directly corresponds to the 'Director's Dealing' category. Filing Type Code Mapping: - DIRS: Director's Dealing (Report of personal share transactions by company directors and executives (insider trades)). This is the most accurate fit.
2025-06-20 Polish
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego / Notification from person discharging managerial responsibilities in the Company due to ...
Share Issue/Capital Change Classification · 1% confidence The document is a 'Report Content Notification' concerning a transaction by a person discharging managerial responsibilities (Mrs. Justyna Żółtek) due to the execution of a Stock Grant Program. This directly relates to insider trading or executive share transactions. The definition for Director's Dealing (DIRS) covers 'Report of personal share transactions by company directors and executives (insider trades)'. Although the notification states the actual notification is 'attached to this report', the core subject matter is the director's dealing, making DIRS the most specific fit over a general RPA or RNS, especially since the document itself is the notification mechanism.
2025-06-20 English
Powiadomienie od osoby pełniącej obowiązki zarządcze w Spółce w związku z realizacją Programu Motywacyjnego / Notification from person discharging managerial responsibilities in the Company due to ...
Director's Dealing Classification · 1% confidence The document text is very short (532 characters) and states that the Management Board (Zarząd) received a notification based on MAR Article 19(1) from a member of the Management Board (Pani Justyna Żółtek) regarding the execution of a Motivational Program. Crucially, the text concludes with: "Treść powiadomienia stanowi załącznik do niniejszego raportu" (The content of the notification constitutes an attachment to this report). This structure—a brief announcement stating that the actual detailed information (in this case, a director's dealing/insider transaction notification) is attached—strongly suggests this is an announcement about a filing rather than the filing itself. Since the content relates to a transaction by a director/executive (Pani Justyna Żółtek, Członka Zarządu), the most specific category is Director's Dealing (DIRS). However, given the 'MENU VS MEAL' rule, if the actual MAR 19 notification is the attachment, this announcement itself is often classified as a general Regulatory Filing (RNS) or, if the content is purely about the transaction, DIRS. Since MAR Article 19 notifications are specifically about insider transactions by management, DIRS is the most appropriate specific category, even if this document is just the cover letter/announcement.
2025-06-20 Polish
Notyfikacja_Tadeusz Wesołowski
Major Shareholding Notification Classification · 1% confidence The document is titled "Zawiadomienie na podstawie art. 69 ust. 1 lub 2 oraz art. 69a ust. 1 lub 3 ustawy o ofercie (wypełnia akcjonariusz)" which translates to a notification based on specific articles of the Polish Public Offering Act concerning changes in shareholding. The content details the 'Stan posiadania podmiotu' (shareholding status) before and after transactions, specifically mentioning the acquisition of shares ('Nabycie 357377 akcji Spółki poza rynkiem regulowanym' and 'Nabycie 8078 akcji Spółki poza rynkiem regulowanym'). This type of filing, reporting changes in significant share ownership thresholds by an individual shareholder or entity, directly corresponds to the definition of Major Shareholding Notification (MRQ).
2025-06-18 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.